疼痛感受器中的大麻素CB1受体通过抑制ASIC3实现术后镇痛作用
Cannabinoid CB1 Receptor in Nociceptors Mediates Postoperative Analgesia via ASIC3 Inhibition
Kangtai Xu, Luyao Ji, Haoyi Yang, Xiying Chen, Qiaodan Hu, Haimei He, Jiawei Wu, Leyan Shan, Shihui Feng, Yingzhi Li, Xiongchang Tan, Hao Wang, Zilong Wang, Chaoran Wu
Journal:Advanced Science
IF:14.1
DOI:10.1002/advs.77925
PMID:42801722
Published:2026-09-27
research field:辐射生物学分子生物学癌症生物学干细胞研究胃肠病学表观遗传学
Abstract
Peripherally restricted analgesics devoid of central side effects are urgently needed for postoperative pain management. The cannabinoid type-1 receptor (CB 1 R) expressed on primary sensory neurons represents an attractive peripheral target, yet its specific role and mechanism in postoperative pain remain poorly defined. Here, by constructing a mouse model of plantar incision and combining with nociceptor-selective Cnr1 knockout and site-specific pharmacology, we revealed that activation of CB 1 R in primary sensory neurons robustly alleviates postoperative mechanical allodynia. Peripheral CB 1 R co-localizes and physically associates with the proton-sensing ion channel ASIC3 in CGRP + peptidergic nociceptors in the dorsal root ganglion (DRG). The activation of CB 1 R signaling suppresses ASIC3-mediated inward currents and subsequent calcium transients, thereby reducing neuronal excitability and ERK 1/2 phosphorylation in nociceptors. Consequently, targeted activation of CB 1 R or blockade of ASIC3 signaling significantly alleviated postoperative pain hypersensitivity and promoted pain resolution. This study elucidated a novel peripheral mechanism by which CB 1 R-ASIC3 physical and functional coupling in peptidergic nociceptors drives the resolution of incisional pain and provided a theoretical basis for the development of peripherally acting, non-opioid analgesic strategies.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


